In addition, patients with low CD276 mRNA expression level had better OS (p = 0.0123) as compared to patients with high CD276 mRNA expression level in the TCGA BLCA cohort (Supplementary Fig. 1e). The gene discussed is CD276; the disease is bladder transitional cell carcinoma.